chr12-52949447-G-C
Variant names: 
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 4P and 2B. PP3_StrongBP6_Moderate
The NM_000224.3(KRT18):c.274G>C(p.Ala92Pro) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
 Genomes: 𝑓 0.47   (  0   hom.,  cov: 38) 
 Exomes 𝑓:  0.00038   (  0   hom.  ) 
 Failed GnomAD Quality Control 
Consequence
 KRT18
NM_000224.3 missense
NM_000224.3 missense
Scores
 13
 5
 1
Clinical Significance
Conservation
 PhyloP100:  5.62  
Publications
10 publications found 
Genes affected
 KRT18  (HGNC:6430):  (keratin 18) KRT18 encodes the type I intermediate filament chain keratin 18. Keratin 18, together with its filament partner keratin 8, are perhaps the most commonly found members of the intermediate filament gene family. They are expressed in single layer epithelial tissues of the body. Mutations in this gene have been linked to cryptogenic cirrhosis. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008] 
 KRT8  (HGNC:6446):  (keratin 8) This gene is a member of the type II keratin family clustered on the long arm of chromosome 12. Type I and type II keratins heteropolymerize to form intermediate-sized filaments in the cytoplasm of epithelial cells. The product of this gene typically dimerizes with keratin 18 to form an intermediate filament in simple single-layered epithelial cells. This protein plays a role in maintaining cellular structural integrity and also functions in signal transduction and cellular differentiation. Mutations in this gene cause cryptogenic cirrhosis. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2012] 
KRT8 Gene-Disease associations (from GenCC):
- cirrhosis, familialInheritance: AR, Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.962
BP6
Variant 12-52949447-G-C is Benign according to our data. Variant chr12-52949447-G-C is described in ClinVar as Benign. ClinVar VariationId is 1205843.Status of the report is criteria_provided_single_submitter, 1 stars. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| KRT18 | NM_000224.3 | c.274G>C | p.Ala92Pro | missense_variant | Exon 1 of 7 | ENST00000388835.4 | NP_000215.1 | |
| KRT18 | NM_199187.2 | c.274G>C | p.Ala92Pro | missense_variant | Exon 2 of 8 | NP_954657.1 | ||
| KRT8 | NM_001256293.2 | c.-47+268C>G | intron_variant | Intron 1 of 8 | NP_001243222.1 | |||
| KRT8 | NR_045962.2 | n.405+9C>G | intron_variant | Intron 1 of 8 | 
Ensembl
Frequencies
GnomAD3 genomes  0.466  AC: 40011AN: 85882Hom.:  0  Cov.: 38 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
40011
AN: 
85882
Hom.: 
Cov.: 
38
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF:  0.000383  AC: 508AN: 1328096Hom.:  0  Cov.: 36 AF XY:  0.000410  AC XY: 270AN XY: 659320 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
GnomAD4 exome 
Data not reliable, filtered out with message: AS_VQSR
 AF: 
AC: 
508
AN: 
1328096
Hom.: 
Cov.: 
36
 AF XY: 
AC XY: 
270
AN XY: 
659320
show subpopulations 
 ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
African (AFR) 
 AF: 
AC: 
7
AN: 
30284
American (AMR) 
 AF: 
AC: 
8
AN: 
40962
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
5
AN: 
21784
East Asian (EAS) 
 AF: 
AC: 
25
AN: 
29494
South Asian (SAS) 
 AF: 
AC: 
19
AN: 
82656
European-Finnish (FIN) 
 AF: 
AC: 
111
AN: 
39952
Middle Eastern (MID) 
 AF: 
AC: 
116
AN: 
4262
European-Non Finnish (NFE) 
 AF: 
AC: 
181
AN: 
1026418
Other (OTH) 
 AF: 
AC: 
36
AN: 
52284
 ⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals. 
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.249 
Heterozygous variant carriers
 0 
 80 
 160 
 239 
 319 
 399 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 10 
 20 
 30 
 40 
 50 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.466  AC: 40039AN: 85958Hom.:  0  Cov.: 38 AF XY:  0.465  AC XY: 19905AN XY: 42852 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. 
GnomAD4 genome 
Data not reliable, filtered out with message: AS_VQSR;InbreedingCoeff
 AF: 
AC: 
40039
AN: 
85958
Hom.: 
Cov.: 
38
 AF XY: 
AC XY: 
19905
AN XY: 
42852
show subpopulations 
 ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. 
African (AFR) 
 AF: 
AC: 
10626
AN: 
23554
American (AMR) 
 AF: 
AC: 
4028
AN: 
8542
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
951
AN: 
1986
East Asian (EAS) 
 AF: 
AC: 
1204
AN: 
2654
South Asian (SAS) 
 AF: 
AC: 
1168
AN: 
2544
European-Finnish (FIN) 
 AF: 
AC: 
3151
AN: 
6654
Middle Eastern (MID) 
 AF: 
AC: 
56
AN: 
120
European-Non Finnish (NFE) 
 AF: 
AC: 
18070
AN: 
38214
Other (OTH) 
 AF: 
AC: 
525
AN: 
1152
 ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals. 
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.269 
Heterozygous variant carriers
 0 
 3924 
 7849 
 11773 
 15698 
 19622 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 502 
 1004 
 1506 
 2008 
 2510 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
ClinVar
Significance: Benign 
Submissions summary: Benign:3 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not specified    Benign:1 
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Pathogenic 
 BayesDel_addAF 
 Pathogenic 
D 
 BayesDel_noAF 
 Pathogenic 
 DANN 
 Uncertain 
 DEOGEN2 
 Pathogenic 
D;.;D 
 Eigen 
 Pathogenic 
 Eigen_PC 
 Pathogenic 
 FATHMM_MKL 
 Pathogenic 
D 
 LIST_S2 
 Pathogenic 
D;D;. 
 M_CAP 
 Pathogenic 
D 
 MetaRNN 
 Pathogenic 
D;D;D 
 MetaSVM 
 Pathogenic 
D 
 MutationAssessor 
 Pathogenic 
H;.;H 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Uncertain 
D;D;D 
 REVEL 
 Pathogenic 
 Sift 
 Uncertain 
D;D;D 
 Sift4G 
 Uncertain 
D;D;D 
 Polyphen 
D;D;D 
 Vest4 
 MVP 
 MPC 
 1.7 
 ClinPred 
D 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.